Original Research
Published on 23 Nov 2022
An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy
in Cancer Immunity and Immunotherapy
- 7,486 views
- 11 citations
Original Research
Published on 23 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Aug 2020
in Molecular and Cellular Oncology
Original Research
Published on 30 May 2022
in Molecular Recognition
Original Research
Published on 24 Mar 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 09 Sep 2025
in Nanobiotechnology
Case Report
Published on 13 May 2025
in Cancer Imaging and Image-directed Interventions
Original Research
Published on 02 Jun 2023
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 26 May 2022
in Thoracic Oncology
Case Report
Published on 11 Jun 2021
in Molecular and Cellular Oncology
Case Report
Published on 06 May 2024
in Thoracic Oncology
Case Report
Published on 25 Mar 2024
in Thoracic Oncology
Original Research
Published on 18 Apr 2024
in Thoracic Oncology
Case Report
Published on 13 Oct 2023
in Cancer Genetics
Case Report
Published on 09 Aug 2024
in Thoracic Oncology
Review
Published on 11 Jun 2024
in Thoracic Oncology
Case Report
Accepted on 12 Feb 2026
in Thoracic Oncology